Paget's Disease of Bone

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition

Volumn , Issue , 2009, Pages 335-343

  Siris, Ethel S ^a   Roodman, G David ^b  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bisphosphonates; Paget's disease

Indexed keywords

EID: 70349142228     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470623992.ch72     Document Type: Chapter

References (52)

1. Kanis JA 1998 Pathophysiology and Treatment of Paget's Disease of Bone, 2nd ed. Martin Dunitz, London, UK.
2. Siris ES, Canfield RE, Jacobs TP 1980 Paget's disease of bone. Bull NY Acad Med 56:285-304.
3. Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo IM, Lopez-Abente G 1995 Frequency and characteristics of familial aggregation of Paget's disease of bone. J Bone Miner Res 10:663-670.
4. McKusick VA 1972 Heritable Disorders of Connective Tissue, 5th ed. CV Mosby, St. Louis, MO, USA.
5. Siris ES, Ottman R, Flaster E, Kelsey JL 1991 Familial aggregation of Paget's disease of bone. J Bone Miner Res 6:495-500.
6. Sparks AB. Peterson SN, Bell C, Loftus BJ, Hocking L, Cahill DP, Frassica FJ, Streeten EA, Levine MA, Fraser CM, Adams MD, Broder S, Venter JC, Kinzler KW, Vogelstein B, Ralston SH 2001 Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma. Calcif Tissue Int 68:151-155.
7. Hocking L, Slee F, Haslam SI, Cundy T, Nicholson G, van Hul W, Ralston SH 2000 Familial Paget's disease of bone: Patterns of inheritance and frequency of linkage to chromosome 18q. Bone 26:577-580.
8. Laurin N, Brown JP, Morissette J, Raymond V 2002 Recurrent mutation of the gene encoding sequestosome 1 (SQSTMl/p62) in Paget disease of bone. Am J Hum Genet 70:1582-1588.
9. Hocking LJ, Herbert CA, Nicholls RK, Williams F, Bennett ST, Cundy T, Nicholson GC, Wuyts W, Van Hul W, Ralston SH 2001 Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10pl3, and 5q35. Am J Hum Genet 69:1055-1061.
10. Kurihara N, Hiruma Y, Zhou H, Subler MA, Dempster DW, Singer FR, Reddy SV. Gruber HE, Windle JJ, Roodman GD 2007 Mutation of the Sequestosome 1 (p62) gene increases osteoclas-togenesis but does not induce Paget's disease. J Clin Invest 117:133-142.
11. Barker DJP, Chamberlain AT, Guyer PH, Gardner MJ 1980 Paget's disease of bone: The Lancashire focus. BMJ 280:1105-1107.
12. Cooper C, Schafheutie K, Dennison E, Kellingray S, Guyer P, Barker D 1999 The epidemiology of Paget's disease in Britain: Is the prevalence decreasing? J Bone Miner Res 14:192-197.
13. Cundy T, McAnulty K, Wattie D, Gamble G, Rutland M, Ibbert-son HK 1997 Evidence for secular changes in Paget's disease. Bone 20:69-71.
14. Rebel A, Malkani K, Basle M, Bregeon C 1997 Is Paget's disease of bone a viral infection? Calcif Tissue Res 22(Suppl):283-286.
15. Mills BG, Singer FR, Weiner LP, Suffin SC, Stabile E, Holst P 1984 Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin Orthop 183:303-311.
16. Gordon MT, Mee AP, Sharpe PT 1994 Paramyxoviruses in Paget's disease. Semin Arthritis Rheum 23:232-234.
17. Mee AP, Dixon JA, Hoyland JA, Davies M, Selby PL, Mawer EB 1998 Detection of canine distemper virus in 100% of Paget's disease samples by in situ-reverse transcriptase-polymerase chain reaction. Bone 23:171-175.
18. Kurihara N, Reddy SV, Menaa C, Anderson D, Roodman GD 2000 Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest 105:607-614.
19. Ooi CG, Walsh CA, Gallagher JA, Fraser WD 2000 Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 27:417-121.
20. Kurihara N, Zhou H. Reddy SV, Garcia-Palacios V, Subler MA. Dempster DW, Windle JJ, Roodman GD 2006 Expression of measles virus nucleocapsid protein in osteoclasts indures Paget's disease-like bone lesions in mice. J Bone Miner Res 21:446-455.
21. Rebel A, Basle M. Pouplard A, Malkani K, Filmon R, Lepatezour A 1980 Bone tissue in Paget's disease of bone: Ultrastructure and immunocytology. Arthritis Rheum 23:1104-1114.
22. Singer FR, Mills BG, Gruber HE, Windle JJ, Roodman GD 2006 Ultrastructure of bone cells in Paget's disease of bone. J Bone Miner Res 21:S2;P51-P54.
23. Shankar S, Hosking DJ 2006 Biochemical assessment of Paget's disease of bone. J Bone Miner Res 21:S2;P22-P27.
24. Meunier PJ, Coindre JM, Edouard CM, Arlot ME 1980 Bone histomorphometry in Paget's disease: Quantitative and dynamic analysis of pagetic and non-pagetic bone tissue. Arthritis Rheum 23:1095-1103.
25. Siris ES, Clemens TP, McMahon D, Gordon AG, Jacobs TP, Can-field RE 1989 Parathyroid function in Paget's disease of bone. J Bone Miner Res 4:75-79.
26. Siris ES, Canfield RE 1994 The parathyroids and Paget's disease of bone. In: Bilezikian J, Levine M, Marcus R (eds.) The Parathyroids. Raven Press, New York, NY, USA, pp. 823-828.
27. Siris ES 1991 Indications for medical treatment of Paget's disease of bone. In: Singer FR, Wallach S (eds.) Paget's Disease of Bone: Clinical Assessment. Present and Future Therapy. Elsevier, New York, NY, USA, pp. 44-56.
28. Herzberg L, Bayliss E 1980 Spinal cord syndrome due to noncompressive Paget's disease of bone: A spinal artery steal phenomenon reversible with calcitonin. Lancet 2:13-15.
29. Monsell EM 2004 The mechanism of hearing loss in Paget's disease of bone. Laryngoscope 114:598-606.
30. Barry HC 1980 Orthopedic aspects of Paget's disease of bone. Arthritis Rheum 23:1128-1130.
31. Wick MR, Siegal GP, Unni KK, McLeod RA, Greditzer HB 1981 Sarcomas of bone complicating osteitis deformans (Paget's disease). Am J Surg Pathol 5:47-59.
32. Hansen MF, Seton M, Merchant A 2006 Osteosarcoma in Paget's disease of bone. J Bone Miner Res 21:S2;P58-P63.
33. Upchurch KS, Simon LS, Schiller AL, Rosenthal DI, Campion EW, Krane SM 1983 Giant cell reparative granulomas of Paget's disease of bone: A unique clinical entity. Ann Intern Med 98:3540.
34. Jacobs TP, Michelsen J, Polay J, D'Adamo AC, Canfield RE 1979 Giant cell tumor in Paget's disease of bone: Familial and geographic clustering. Cancer 44:742-747.
35. Strickenberger SA, Schulman SP, Hutchins GM 1987 Association of Paget's disease of bone with calcific aortic valve disease. Am J Med 82:953-956.
36. Sundaram M 2006 Imaging of Paget's disease and fibrous dysplasia of bone. J Bone Miner Res 21:S2;P28-P30.
37. Siris ES, Lyles KW, Singer FR, Meunier PJ 2006 Medical management of Paget's disease of bone: Indications for treatment and review of current therapies. J Bone Miner Res 21:S2;94-98.
38. El-Sammaa M, Linthicum FH, House HP, House JW 1986 Calcitonin as treatment for hearing loss in Paget's disease. Am J Otol 7:241-243.
39. Murdin L, Yeoh LH 2005 Hearing loss treated with Pamidronate. J R Soc Med 98:272-274.
40. Meunier PI, Vignot E 1995 Therapeutic strategy in Paget's disease of bone. Bone 17:489S-491S.
41. Selby PL, Davie MWJ, Ralston SH, Stone MD 2002 Guidelines on the management of Paget's disease of bone. Bone 31:366-373.
42. Kaplan FS 1999 Surgical management of Paget's disease. J Bone Miner Res 14:S2;34-38.
43. Drake WM, Kendler DL, Brown JP 2001 Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance Symposium. Clin Ther 23:620-626.
44. Canfield R, Rosner W, Skinner J, McWhorter J, Resnick L, Feldman F, Kammerman S, Ryan K, Kunigonis M, Bohne W 1977 Diphosphonate therapy of Paget's disease of bone. J Clin Endocrinol Metab 44:96-106.
45. McClung MR, Tou CPK, Goldstein NH, Picot C 1995 Tiludronate therapy for Paget's disease of bone. Bone 17:493S-196S.
46. Harinck HI, Papapoulos SE, Blanksrna HJ, Moolenaar AJ, Ver-meij P, Bijvoet OL 1987 Paget's disease of bone: Early and late responses to three different modes of treatment with aminohy-droxypropylidene bisphosphonate (APD). BMJ 295:1301-1305.
47. Gutteridge DH, Ward LC, Stewart GO, Retallack RW, Will RK, Prince RL, Criddle A, Bhagat CI, Stuckey BG, Price RI, Kent GN, Faulkner DL, Geelhoed E, Gan SK, Vasikaran S 1999 Paget's disease: Acquired resistance to one aminobisphosphonate with retained response to another. J Bone Miner Res 14:S2;79-84.
48. Siris E, Weinstein RS, Altman R, Conte JM, Favus M, Lombardi A. Lyles K, Mcllwain H, Murphy WA Jr, Reda C, Rude R, Seton M, Tiegs R, Thompson D, Tucci JR, Yates AJ, Zimering M 1996 Comparative study of alendronate vs. etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab 81:961-967.
49. Miller PD, Adachi JD, Brown JP, Khairi RA, Lang R, Licata AA, McClung MR, Ryan WG, Singer FR, Siris ES, Tenenhouse A, Wallach S, Bekker PJ, Axelrod DW 1997 Risedronate vs. etidronate: Durable remission with only two months of 30 mg risedronate. J Bone Miner Res 12:S269.
50. Reid IR, Miller P, Lyles K, Fraser W, Brown J, Saidi Y, Mesen-brink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D 2005 A single infusion of zoledronic acid improves remission rates in Paget's disease: A randomized controlled comparison with risedronate. N Engl J Med 353:898-908.
51. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E; American Society for Bone and Mineral Research. 2007 Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479-1491.
52. Parvizi J, Klein GR, Sim FH 2006 Surgical management of Paget's disease of bone. J Bone Miner Res 21:S2;P75-P82.